Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Corcept Therapeutics shares are trading higher after the company reported better than expected Q2 financial results and raised its FY24 revenue guidance above estimates. Also, HC Wainwright & Co and Piper Sandler raised their respective price targets on the stock.

Author: Benzinga Newsdesk | July 30, 2024 07:45am

Posted In: CORT